|
"paik seung woon"的相關文件
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T15:38:46Z |
Gut-derived cholecystokinin contributes to visceral hypersensitivity via nerve growth factor-dependent neurite outgrowth
|
陳培哲; Hsu, Luo-Ting;Hung, Kuan-Yang;Wu, Hsiu-Wei;Liu, Wei-Wen;She, Meng-Ping;Lee, Tsung-Chun;Sun, Chin-Hung;Yu, Wei-Hsuan;Buret, Andre G.;Yu, Linda Chia-Hui; Hsu, L.-T. and Hung, K.-Y. and Wu, H.-W. and Liu, W.-W. and She, M.-P. and Lee, T.-C. and Sun, C.-H. and Yu, W.-H. and Buret, A.G. and Yu, L.C.-H.; 余佳慧;游偉絢;李宗錞; Hsu, Luo-Ting; Cheng, Ann Lii; LINDA CHIA-HUI YU; WEI-HSUAN YU; Hung, Kuan-Yang; Amarapurkar, Deepak; Chao, Yee; Wu, Hsiu-Wei; Liu, Wei-Wen; Chen, Pei-Jer; She, Meng-Ping; Geschwind, Jean-Francois; Lee, Tsung-Chun; Goh, Khean L.; Han, Kwang-Hyub; Sun, Chin-Hung; Yu, Wei-Hsuan; Kudo, Masatoshi; Buret, Andre G.; Lee, Han Chu; Lee, Rheun-Chuan; Yu, Linda Chia-Hui; Lesmana, Laurentius A.; Lim, Ho Yeong; Paik, Seung Woon; Poon, Ronnie T.; Tan, Chee-Kiat; Tanwandee, Tawesak; Teng, Gaojun; Park, Joong-Won; 鄭安理 |
| 國立成功大學 |
2016-11 |
A mild and reversible Health Related Quality of Life (HRQL) impairments is observed in Asian patients with Hepatitis C Virus (HCV) infection who are treated with ribavirin-containing regimens
|
Younossi, Zobair; Stepanova, Maria; Han, Kwang-Hyub; Jeong, Sook-Hyang; Paik, Seung-Woon; Chang, Ting-Tsung; Chu, Chi-Jen; Chan, Henry Lik-Yuen; Lai, Ching-Lung; Hunt, Sharon |
| 國立成功大學 |
2016-10 |
Comparison of Health-Related Quality of Life (HRQL) in Asian Patients with Chronic Hepatitis C Treated with Interferon (IFN)-free Ribavirin (RBV)-Containing Regimens vs Interferon-free and Ribavirin-free Regimens
|
Younossi, Zobair M.;Stepanova, Maria;Han, Kwang-Hyub;Chuang, Wan-Long;Chan, Henry Lik-Yuen;Lim, Young-Suk;Chien, Rong-Nan;Ahn, Sang Hoon;Jeong, Sook-Hyang;Chang, Ting-Tsung;Paik, Seung Woon;Peng, Cheng-Yuan;Chu, Chi-Jen;Lee, Youn-Jae;Lai, Ching-Lung;Kao, Jia-Horng;Hunt, Sharon |
| 國立臺灣大學 |
2014 |
Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel
|
Cheng, Ann Lii; Amarapurkar, Deepak; Chao, Yee; Chen, Pei-Jer; Geschwind, Jean-Francois; Goh, Khean L.; Han, Kwang-Hyub; Kudo, Masatoshi; Lee, Han Chu; Lee, Rheun-Chuan; Lesmana, Laurentius A.; Lim, Ho Yeong; Paik, Seung Woon; Poon, Ronnie T.; Tan, Chee-Kiat; Tanwandee, Tawesak; Teng, Gaojun; Park, Joong-Won; 鄭安理; 陳培哲 |
| 國立臺灣大學 |
2013 |
Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)
|
Park, Joong-Won; Amarapurkar, Deepak; Chao, Yee; Chen, Pei-Jer; Geschwind, Jean-Francois H.; Goh, Khean Lee; Han, Kwang-Hyub; Kudo, Masatoshi; Lee, Han Chu; Lee, Rheun-Chuan; Lesmana, Laurentius A.; Lim, Ho Yeong; Paik, Seung Woon; Poon, Ronnie T.; Tan, Chee-Kiat; Tanwandee, Tawesak; Teng, Gaojun; Cheng, Ann-Lii; 鄭安理; 陳培哲 |
| 國立臺灣大學 |
2012 |
Brivanib (BRI) versus Sorafenib (SOR) as First-line Therapy in Patients with Unresectable, Advanced Hepatocellular Carcinoma (HCC): Results from the Phase 3 BRISK-FL Study
|
Johnson, Phillip; Qin, Shukui; Park, Joong-Won; Poon, Ronnie T.; Raoul, Jean-Luc; Philip, Philip A.; Hsu, Chih-Hung; Hu, Tsung-Hui; Heo, Jeong; Xu, Jianming; Lu, Ligong; Chao, Yee; Boucher, Eveline; Han, Kwang-Hyub; Paik, Seung Woon; Robles-Avina, Jorge; Kudo, Masatoshi; Liu, David; Ezzeddine, Rana; Walters, Ian; Cheng, Ann-Lii; 鄭安理; 徐志宏 |
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
|
